These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 32329697

  • 1. Anti-Metastatic Effects of Lupeol via the Inhibition of MAPK/ERK Pathway in Lung Cancer.
    Bhatt M, Patel M, Adnan M, Reddy MN.
    Anticancer Agents Med Chem; 2021; 21(2):201-206. PubMed ID: 32329697
    [Abstract] [Full Text] [Related]

  • 2. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells.
    Luo W, Liu Q, Jiang N, Li M, Shi L.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31467176
    [Abstract] [Full Text] [Related]

  • 3. Oroxylin A inhibits invasion and migration through suppressing ERK/GSK-3β signaling in snail-expressing non-small-cell lung cancer cells.
    Wei L, Yao Y, Zhao K, Huang Y, Zhou Y, Zhao L, Guo Q, Lu N.
    Mol Carcinog; 2016 Dec 30; 55(12):2121-2134. PubMed ID: 26741501
    [Abstract] [Full Text] [Related]

  • 4. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
    Hsieh YS, Liao CH, Chen WS, Pai JT, Weng MS.
    J Cell Biochem; 2017 Dec 30; 118(12):4639-4651. PubMed ID: 28485480
    [Abstract] [Full Text] [Related]

  • 5. Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action.
    Sławińska-Brych A, Mizerska-Kowalska M, Król SK, Stepulak A, Zdzisińska B.
    Cells; 2021 Jun 12; 10(6):. PubMed ID: 34204745
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A Ferulic Acid Derivative FXS-3 Inhibits Proliferation and Metastasis of Human Lung Cancer A549 Cells via Positive JNK Signaling Pathway and Negative ERK/p38, AKT/mTOR and MEK/ERK Signaling Pathways.
    Yue SJ, Zhang PX, Zhu Y, Li NG, Chen YY, Li JJ, Zhang S, Jin RY, Yan H, Shi XQ, Tang YP, Duan JA.
    Molecules; 2019 Jun 08; 24(11):. PubMed ID: 31181779
    [Abstract] [Full Text] [Related]

  • 8. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ, Choi YS, Lee S, Lee YJ, Hong S, Han S, Kim BC.
    Cancer Lett; 2016 Oct 28; 381(2):314-22. PubMed ID: 27543359
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
    Luo W, Liu X, Sun W, Lu JJ, Wang Y, Chen X.
    Phytother Res; 2018 Oct 28; 32(10):2009-2020. PubMed ID: 29952428
    [Abstract] [Full Text] [Related]

  • 16. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H.
    Toxicology; 2014 Aug 01; 322():23-33. PubMed ID: 24793912
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.